4 days ago
- Business
- New Straits Times
UWC Q3 earnings up 98pct on semiconductor rebound, no dividend declared
KUALA LUMPUR: UWC Bhd's net profit for the third quarter ended April 30, 2025, nearly doubled to RM7.96 million from RM4.02 million a year earlier, driven by a strong recovery in the semiconductor market.
Revenue for the quarter climbed 45 per cent to RM95.56 million from RM66 million, boosted by improved demand from the semiconductor segment, which remains the company's largest revenue contributor.
In a filing with Bursa Malaysia today, the group said the rebound in semiconductor demand helped lift its pre-tax profit to RM9.76 million, up from RM6.53 million a year earlier.
Earnings per share for the quarter rose to 72 sen from 36 sen previously. No dividend was declared for the quarter.
As at April 30, UWC's cash and bank balances stood at RM26.57 million, down from RM80.99 million at end-July 2024, due to significant capital expenditure and a net operating cash outflow of RM13.33 million.
Total liabilities increased to RM92.32 million from RM65.70 million, while borrowings amounted to RM9 million compared to zero previously, reflecting new banker acceptance and revolving credit facilities.
Looking ahead, the company said future prospects are underpinned by continued project wins and capacity expansion in front-end semiconductor, electric vehicle and medical technology segments.
"The group still maintains an optimistic outlook towards both its business and the industries in which it operates in for the coming years while currently observing signs of recovery," it said.
UWC said it is actively undertaking new construction and production capacity expansion projects to cater to growing demand, particularly in artificial intelligence-related semiconductor manufacturing and next-generation life science technologies.
"With a robust pipeline of new building projects and focus on capital expenditure, the group will be well positioned for substantial growth and long-term value creation of the front-end semiconductor business," it added.
It also expects growth in the life science and medical technology segment to remain strong, supported by ongoing customer wins and increased demand for DNA analysers, virus extraction machines and precision mobility products.
